Stryker Appoints Spencer Stiles as CEO, Kevin Lobo to Become Executive Chair

Amériquesdernières nouvellesDéveloppement stratégiqueChirurgicalActualité à la Une

Stryker has announced that, as part of a planned succession process, Kevin Lobo will transition to the role of Executive Chair of the Board of Directors, effective January 1, 2027. Spencer Stiles, currently President and Chief Operating Officer of Stryker, will succeed Lobo as Chief Executive Officer and will also be appointed as a member of the company’s Board at that time.

Lobo has led a career at Stryker spanning more than 15 years, joining the company in 2011 as Group President, becoming Chief Executive Officer in October 2012, and being appointed Chair of the Board in July 2014. During his 14-year tenure as CEO, Lobo significantly expanded Stryker’s portfolio and global presence, tripling annual net sales from $8.7 billion in 2012 to more than $26 billion in 2026. Under his leadership, Stryker completed more than 60 acquisitions, including Mako, which combined robotic-arm-assisted technology with Stryker’s joint-reconstruction expertise to transform the orthopaedic industry. Lobo also helped shape the culture that defines Stryker today, establishing its mission to make healthcare better together with its customers and advancing a specialized business operating model that has supported the company’s performance and growth.

Stiles is a strategic, growth-oriented, and people-focused leader with a record of execution throughout a career at Stryker spanning nearly three decades. Since joining the company’s Endoscopy business in 1999, Stiles has held leadership roles across nearly every Stryker business, spanning Orthopaedics, MedSurg, and Neurotechnology. Before becoming President and Chief Operating Officer in January 2026, Stiles served as Group President of Orthopaedics, leading the company’s Joint Replacement and Trauma and Extremities businesses and its Digital, Robotics, and Enabling Technologies organization, with additional responsibility for international regions and Stryker’s enterprise mergers and acquisitions strategy. Stiles has also led significant portfolio initiatives, including the acquisition of Wright Medical, which enhanced Stryker’s global market position in trauma and extremities, and the separation of the company’s spinal implants business.

Kevin Lobo said serving as CEO of Stryker has been an incredible honor, and that he is proud of all that the company’s teams have accomplished together on behalf of customers and the patients they serve. Lobo noted that the Board and he have worked closely on a succession plan, and that with a strong foundation in place, now is the right time for this leadership transition. Lobo added that having worked alongside Stiles for many years, he has seen firsthand the qualities that define Stiles’ leadership, including the ability to set a clear direction, inspire people, and translate strategy into strong execution, and expressed confidence that Stiles will build on the company’s momentum.

Spencer Stiles said he is honored to be named Stryker’s next CEO and grateful to the Board and Lobo for their trust. Stiles noted that he has a deep appreciation for the company’s people, culture, and customer relationships that drive its innovation and growth, and that Lobo has built an extraordinary legacy and a strong foundation for the future, which he is excited to build upon as the company continues executing its strategy, driving growth, and advancing its mission to make healthcare better.

Sheri McCoy, Lead Independent Director of Stryker’s Board of Directors, said the announcement is the culmination of a comprehensive, long-term succession planning process. McCoy noted that Stiles is a proven leader with strategic perspective and the ability to unite teams around shared priorities, and that the Board is confident he is the right leader to guide the company’s next chapter. McCoy also recognized Lobo for his exceptional leadership and service, noting that he has positioned Stryker to enter this transition from a place of strength, and that the company is fortunate to continue benefiting from his experience and perspectives as Executive Chair.